• Keine Ergebnisse gefunden

Supplemental digital content

N/A
N/A
Protected

Academic year: 2022

Aktie "Supplemental digital content"

Copied!
5
0
0

Wird geladen.... (Jetzt Volltext ansehen)

Volltext

(1)

Supplemental digital content

Figure S1 Experimental procedure Figure S2 Flow chart of study participants Figure S3 Troponin T levels after surgery

Table S1 Pre- and postoperative MIF concentration in serum samples Table S2 Pre- and postoperative CXCL12 concentration in serum samples

(2)

Figure S1 Experimental procedure. Blood samples were drawn prior to surgery, after

RIPC by 4 cycles of 5min arm ischemia/5 min reperfusion (n=19) and sham (n=21) procedure, after connection to cardiopulmonary bypass (CPB), at the end of surgery, 24h postoperatively and 48h after surgery.

(3)

Figure S2. Flow chart of study participants.

Eligible and enrolled in study (n= 63)

Ineligible for study (n= 23)

Allocated to control (n=21)

Included in final analysis (n=21) Included in final analysis (n=19) Randomized (n= 40)

Blood samples

1403 Patients enrolled in total in the RIPHeart Study;

RWTH Aachen (n=63)

Allocated to RIPC (n=19)

Blood samples

Right atrial samples Right atrial

samples

(4)

preop

6 h postop

12 h postop

24 h postop

48 h postop 0

1 0 0 0 2 0 0 0 3 0 0 0

Troponin T (pg/ml)

C o n t r o l R I P C

Figure S3. Troponin T levels after surgery. Troponin T levels were measured before surgery (Pre-OP) and 6h, 12h, 24h, 48h after cardiac surgery. Data represents means+/- SD.

(5)

Table S1 MIF data.

Table S2 CXCL12 data.

Control group (n=21) RIPC group (n=19) MIF (ng/ml) Mean ± SD p-value

compared to baseline

Mean ± SD p-value compared to baseline

p-value comparing

groups A (before

surgery)

53.4 ±53.31 1 57.35

±60.99 1 0.828

X (after RIPC, before HLM)

71.58

±63.51

0.255 61.62

±69.15

0.802 0.665

B (ICU admission)

90.59

±69.26 0.023 84.9 ±82.7 0.164 0.814 D (24h after

surgery)

52 ±63.98 0.921 38.86±46.4 0.10 0.466

E (48h after surgery)

55.54

±38,46 0.812 47.29

±52.28 0.426 0.587

Control group (n=21) RIPC group (n=19) CXCL12

(pg/ml)

Mean ± SD p-value compared

to baseline

Mean ± SD p-value compared

to baseline

p-value comparing

groups

A (before surgery)

276.46±243.45 1 322.29±247.89 1 0.597

X (after RIPC, before HLM)

188.60±140.38 0.029 198.88±113.51 0.001 0.827

B (ICU admission)

912.05±789.81 0.002 793.85±448.23 0.001 0.607

D (24h after surgery)

271.94±226.32 0.934 214.71±128.65 0.008 0.405

E (48h after surgery)

351.08±329.60 0.364 299.34±164.49 0.597 0.587

Referenzen

ÄHNLICHE DOKUMENTE

The observed rise of myocardial adverse events in patients receiving steroids might simply be related to biochemical measurements: the SIRS trial differentiated between

This study demonstrates in a model of severe acute lung injury by ischemia and reperfusion that ebselen pretreat- ment results in a clearly improved gas exchange of the

not fully recover until the end of the experiment, whereas diastolic function remained relatively unchanged in the DXS group (Fig. 2A) and pulmonary artery pressures (Fig. 2B) post-

We compared the intraoperative and early postoperative myocardial damage and outcome of patients who underwent CABG surgery with conventional cardiopulmonary bypass (CPB) or

Under the conditions used for the searches, penalties of —1, 2 , 3 for matches, replacements, deletions/insertions, re- spectively, the expected numbers as calculated are a

AMD, age-related macular degeneration; BCVA, best-corrected visual acuity; NA, not applicable; PCV, polypoidal choroidal vasculopathy; PICOS, Population, Intervention,

Level 2A: Learning (Changes in Attitudes) Details: attitudes regarding the importance of Autism-friendly care, comfort responding to the needs of autistic children, and

Assessment of the function of the heart, usually by measurement of the cardiac output with a (thermo)dilution technique or echocardiography, and dynamics of the markers of